All courses | eHealthHIV

Description

The HealthHIV HIV Treatment Innovation Certificate ProgramTM is designed to prepare and educate experienced HIV care providers (HIV and ID specialists), as well as primary care providers and general practitioners (includes MD/DO, NP, PA, nurses, pharmacists) to treat more complex patient cases and implement recent treatment innovations. By participating in this online program, providers will develop and apply new skills to optimize HIV care for people with HIV (PWH) in their practice. Participants who complete the full certificate program will have an understanding of current antiretroviral (ARV) therapies for optimal HIV treatment, the provider’s role in managing common co-infections and opportunistic infections, treatment optimization strategies, clinical guidelines to treating PWH in key populations, including patients aging with HIV, and a framework for managing treatment-experienced PWH.

There are six on-demand modules in the certificate program, and modules may be completed individually. Upon completion of the entire six-module program, providers can earn a Certificate in HIV Treatment Innovation which demonstrates competency in innovative, multi-level treatment optimization strategies for providing care and treatment to PWH.

Target Audience

This activity is intended for HIV care providers, primary care providers and general practitioners (includes MD/DO, NP, PA), nurses, pharmacists, and other professionals involved in the care of patients with HIV.

Media: Enduring Material
Release date for Modules 1-6: November 4, 2024
Expiration date for Modules 1-6: November 3, 2025
Time to Complete Modules 1-5: 60 minutes
Time to Complete Modules 6: 30 minutes

Educational Objectives

After completing this activity, the participant should be better able to:

Deliver comprehensive and individualized HIV care, including ART treatment and management of antiviral resistance and common coinfections and comorbidities.
Recognize the benefits and flexibility of available regimens for vulnerable patients with HIV, including older adults and treatment-experienced patients.
Apply individualized therapy for patients with HIV that is based on new and emerging strategies and addresses the diverse needs and preferences of individual patients (e.g., adolescents, pregnant persons, unstably housed individuals, and those with substance use disorders) to promote health equity.
Describe new and investigational ART regimens and how they can be utilized to optimize HIV treatment.

Program Agenda

Module 1: Innovations in Antiretroviral Therapies to Optimize HIV Treatment
Module 2: Management of Common Comorbidities for People Living with HIV
Module 3: Considerations in the Management of HIV in Older Adults
Module 4: Improving Health Equity in HIV Management
Module 5: Management of Treatment-Experienced Patients with HIV Drug Resistance
Module 6: Applying HIV Treatment Individualization in Patient Case Scenarios

Accreditation, Credit, and Support

All modules are certified and participants can earn up to 5.5 Credits/Contact Hours (CME, MOC, AAPA, NCPD, CPE) for completion of the certificate.

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and HealthHIV. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Medical Learning Institute, Inc. (MLI) designates the modules within this enduring material for the following AMA PRA Category 1 Credits™ :

Module 1: up to 1.0
Module 2: up to 1.0
Module 3: up to 1.0
Module 4: up to 1.0
Module 5: up to 1.0
Module 6: up to 0.5

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn the following MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Module 1: up to 1.0
Module 2: up to 1.0
Module 3: up to 1.0
Module 4: up to 1.0
Module 5: up to 1.0
Module 6: up to 0.5

ECMEC® Credit

The European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit(s)™ into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).

Medical Learning Institute, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for the following AAPA Category 1 CME credit. Approval is valid until November 3, 2025. PAs should only claim credit commensurate with the extent of their participation.

Module 1: up to 1.0
Module 2: up to 1.0
Module 3: up to 1.0
Module 4: up to 1.0
Module 5: up to 1.0
Module 6: up to 0.5

Nursing Continuing Professional Development

Successful completion of this nursing continuing professional development activity will be awarded the following contact hour and contact hour in the area of pharmacology.

Continuing Pharmacy Education

Medical Learning Institute, Inc. designates this knowledge-based continuing education activity for the following contact hour and CEU of the Accreditation Council for Pharmacy Education.

Module 1: Innovations in Antiretroviral Therapies to Optimize HIV Treatment
JA0007322-9999-24-085-H01-P
Module 2

Interprofessional Continuing Education (IPCE) Statement

This activity was planned by and for the healthcare team, and learners will receive the following Interprofessional Continuing Education (IPCE) credit for learning and change.

Module 1: up to 1.0
Module 2: up to 1.0
Module 3: up to 1.0
Module 4: up to 1.0
Module 5: up to 1.0
Module 6: up to 0.5

Support Statement

This program has been supported by an independent educational grant from Gilead Sciences, Inc.

Disclosure & Conflict of Interest Policy

Medical Learning Institute, Inc. and HealthHIV are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.

Faculty Disclosures

Planning Committee and Content/Peer Reviewers

The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies.

Disclosure of Unlabeled Use

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Disclaimer

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth via email at beth@healthhiv.org.

For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.

For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.

For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.

About This Activity

Medical Learning Institute, Inc. and HealthHIV are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute, Inc. and HealthHIV.

The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute, Inc. or any of its partners, providers, and/or supporters.

Module 1: Innovations in Antiretroviral Therapies to Optimize HIV Treatment

Faculty: Melissa E. Badowski, PharmD, MPH, FCCP, FIDSA, BCIDP, BCPS, AAHIVP

Course Description

This module provides an update on recommended and investigational ARV therapies for optimal HIV care and treatment in HIV care, primary care, and general medicine.

Educational Objectives

Upon completion of this activity, participants should be able to:

Describe recent updates to HIV treatment guidelines, including guidance for optimal HIV treatment in HIV care and primary care settings
Explain innovations in antiretroviral therapy (ART), such as long-acting injectable ART (LA ART)
Identify strategies to monitor patient response to therapy and HIV treatment adherence
Discuss switching patients to more simplified HIV treatment regimens

Module 2: Management of Common Comorbidities for People Living with HIV

Faculty: David A. Wohl, MD

Course Description

This module provides considerations for managing and preventing common comorbidities, co-infections and opportunistic infections among PWH.

Educational Objectives

Upon completion of this activity, participants should be able to:

Identify common comorbidities and co-infections (CIs) among people with HIV and their impact on treatment decisions
Summarize recent updates to HIV treatment guidelines related to co-infections and opportunistic infections (OIs)
Identify strategies to manage common comorbidities and co-infections, including notable medication contraindications
Explain the importance of prevention and wellness discussions with PWH, that includes vaccinations, to reduce impact of CIs and OIs

Module 3: Considerations in the Management of HIV in Older Adults 2024

Faculty: Jonathan S. Appelbaum, MD, FACP, AAHIVS

Course Description

This module provides considerations for managing HIV care among older adults and long-term HIV survivors.

Educational Objectives

Upon completion of this activity, participants should be able to:

Identify common comorbidities most prevalent in older adults with HIV, based on findings from the REPRIEVE study
Discuss strategies and special considerations for managing HIV care in older adults who did not initiate early start on treatment
Evaluate the potential impact of long-term antiretroviral therapy on cardiometabolic risk and other comorbidities in older adults and long-term HIV survivors
Develop strategies for managing both antiretroviral therapy and cardiometabolic risk factors in patients with HIV

Module 4: Improving Health Equity in HIV Management

Faculty: Kathleen A. McManus, MD, MSc, FIDSA

Course Description
This course provides evidence-based HIV treatment optimization strategies for delivering quality HIV care among key populations.

Educational Objectives

Upon completion of this activity, participants should be able to:

Explain inequities in HIV and social determinants of health impacting people with HIV (PWH)
Describe intersectionality of social determinants of health that impact HIV treatment among key populations
Identify model practices for optimizing HIV management/treatment among patients with competing priorities (e.g. persons experiencing homelessness, substance use disorders, transgender persons, young adults)

Module 5: Management of Treatment-Experienced Patients with HIV Drug Resistance 2024

Faculty: Monica Gandhi, MD, MPH

Course Description
This course provides information on the latest strategies for managing treatment of patients with HIV drug resistance.

Educational Objectives

Upon completion of this activity, participants should be able to:

Identify impacts of HIV drug resistance on patients and communities
Identify the causes of virologic failure and methods to assess virologic failure and HIV drug resistance
Identify steps for constructing new treatment regimens for patients with HIV drug resistance
Identify considerations for special populations with HIV drug resistance

Module 6: Applying HIV Treatment Individualization in Patient Case Scenarios

Faculty: Asa E. Radix, MD, PhD, MPH, FIDSA

Course Description
This module offers comprehensive patient cases that require learners to apply knowledge from Modules 1-5 in case-based scenarios.

Educational Objectives

Upon completion of this activity, participants should be able to:

Evaluate HIV management needs of older adults with HIV
Identify unique considerations of HIV management for transgender women
Apply HIV treatment knowledge to determine optimal ART regimens for patients

Final Certificate 2024

After completion of all five modules, please select to receive your final certificate.